Growth control
from the 24th week of pregnancy
Objectives - Identification of
- Detection of any severe malformations
- Circulatory and localization disorders of the placenta and a risk of premature birth
Cost of the examination
€250
The best time for an organ screening is between the 21st and 24th week of pregnancy. From the 21st week of pregnancy, the unborn baby's organs are already sufficiently developed to be examined in detail.
An organ screening is beneficial for every pregnant woman. During the organ screening, the unborn baby is examined thoroughly. All organs, as well as the face, back, chest, diaphragm, abdominal wall, and limbs are checked. In addition, the blood flow in the uterine arteries and thus the fetal oxygen supply are measured using Doppler ultrasound Doppler.
Comprehensive growth control
In the event of anomalous findings, treatments can, if necessary, be carried out while the baby is still in the womb. In addition, it is possible to ensure appropriate delivery management and plan subsequent therapies during pregnancy in cooperation with specialists from other departments (such as neonatology, pediatric, neuro-, or dental surgery). We perform the examination in accordance with the quality criteria of the ÖGUM Level II standards. Our certification stands for qualified prenatal diagnostic examinations using state-of-the-art equipment.
A Doppler blood flow measurement during the examination provides indications of a possible insufficient supply to the child via the placenta (placental insufficiency). The probability of a premature birth is calculated by measuring the cervix length. Upon request, a screening for indicators of chromosomal abnormalities can be carried out during screening 22.
- You will receive the results immediately following the examination.
- If the child's position allows, we will gladly capture a 3D ultrasound image upon request during the examination.
- Your ultrasound images are immediately available to you digitally.
Investigation Timeline
Our prenatal center is equipped with its own laboratory. This makes it possible to carry out examinations entirely in our facility and to inform you of the results very quickly.
Book an appointment
Our prenatal center is equipped with its own laboratory. This allows us to perform all examinations entirely in-house.
Cost of the examination
€250Q&A
The combined test is available to women of any age. The combined test can determine the risk of chromosomal abnormalities, specifically Trisomy 21 (Down syndrome) as well as Trisomy 13 or 18. This risk increases with age. During pregnancy, a combined test can be performed between 11 weeks + 3 days and 13 weeks + 6 days of gestation.
The Combined Test is possible between 11+3 and 13+6 weeks of pregnancy. Ideally, the test is performed between 12+0 and 13+0 weeks of pregnancy. The crown-rump length during this period measures between 45 and 84 mm. Before and after this window, measurement of the nuchal translucency is not possible.
The entire combined test, consisting of a blood test and an ultrasound scan, usually takes 1.5 hours. During this time, the blood collection, an ultrasound scan and the discussion of the results take place. Results are available immediately after the combined test.
A result for the Combined Test is available immediately after the Combined Test examination. The result will be discussed in detail during a consultation. At the end, you will receive a printout of the findings.
The evaluation of the result takes place immediately after the Combined Test and the associated blood draw. The analysis takes about 1.5 hours, after which the result is available.
The nuchal translucency scan (first-trimester screening) is an important part of the combined test. In combination with a blood test of the pregnant woman, the combined test calculates the probability of Down syndrome (trisomy 21), trisomy 13, and 18.
At the prenatal center, the Combined Test costs €250. For twin pregnancies, the Combined Test costs €300.
Preeclampsia (also known as toxemia of pregnancy or EPH gestosis) is a disease affecting pregnant women. It usually occurs after the 20th week of pregnancy and is characterized by high blood pressure and other symptoms such as protein excretion in the urine, elevated liver enzymes, and growth disorders of the unborn child. In the event of an increased risk, the daily intake of 150mg of Thrombo ASS can significantly reduce the risk of preeclampsia.
The probability of preeclampsia (also known as pregnancy-induced hypertension or toxemia) is determined using a preeclampsia screening. This screening is performed in conjunction with a Combined Test at no additional cost or extra time.
Preeclampsia screening is possible between weeks 11+3 and 13+6 of pregnancy. That is at the same time as the combined test.
The cost of the pre-eclampsia screening is included in the combined test.